Diversion Trends

What's trending up in healthcare drug diversion, tracked from recent news and enforcement actions.

By Alex Rodriguez, MHIIM, CPhT — ASHP Drug Diversion Certificate faculty

This page tracks recurring themes in DEA and DOJ press releases, HHS-OIG enforcement actions, and published news reports — updated as new cases emerge. It is designed to complement the static case studies hub with a forward-looking, trend-level view of where enforcement attention is concentrated.

Each trend below includes recent real-world examples and a compliance implication for hospitals and pharmacies. Use this page to prioritize audit focus, staff training topics, and policy updates.

TRENDING NOW
7 Trends Driving Enforcement Activity in 2025–2026
1. Fentanyl Tampering in Hospitals (IV Bags & Vials)
▲ Trending up

Nurses and pharmacy technicians are being arrested for stealing fentanyl IV bags and vials, then replacing the contents with saline or tap water — leaving patients under-medicated or exposed to infection. Cases span ICUs, fertility clinics, and surgical centers across multiple states in 2025–2026, with federal charges and multi-year sentences becoming routine.

Recent examples:

What to watch: Verify every fentanyl and hydromorphone withdrawal against a co-sign or camera capture; run discrepancy reports on high-alert opioids at least weekly. Patient complaints of inadequate pain relief should route to the diversion team, not just nursing or risk management.

2. Anesthesia Provider Diversion (CRNAs & Residents)
▲ Trending up

Anesthesia personnel remain the highest-risk provider group in healthcare diversion. Cases in 2025–2026 span anesthesiology residents diverting narcotics while on duty and CRNAs tampering with fentanyl in ORs. Industry estimates suggest roughly 1 in 10 nurse anesthetists has misused or diverted controlled substances at some point in their career.

Recent examples:

What to watch: Anesthesia waste verification and dispense-then-return audits are the primary control; supplement with surveillance of controlled substances removed from anesthesia carts but not documented in the patient's anesthesia record.

3. Tampering That Harms Patients (Hospice, Labor & Delivery)
▲ Trending up

Federal prosecutors are increasingly charging not just diversion but the downstream patient harm it causes — morphine replaced with juice in hospice, fentanyl replaced with saline in labor and delivery units, and patients denied effective pain relief during procedures. These cases draw federal tampering charges on top of controlled substance violations and carry longer sentences.

Recent examples:

What to watch: Patient complaints of inadequate pain relief are a diversion red flag — treat them as a potential tampering signal and route them directly to the diversion program. High-acuity units (hospice, L&D, oncology) warrant more frequent unannounced audits and co-witness requirements for all opioid waste.

4. Pharmacy & Pharmacist Enforcement Actions
▲ Trending up

DEA Diversion is filing civil complaints, settlement agreements, and criminal conspiracy charges against pharmacies and pharmacists at an accelerating pace in 2025–2026. Targets range from independent pharmacies with poor recordkeeping to licensed pharmacists coordinating illegal prescription fill operations. Immediate Suspension Orders can shut a pharmacy without advance notice.

Recent examples:

What to watch: Controlled substance recordkeeping accuracy, suspicious order monitoring, and response to DEA requests are the primary tripwires. Audit controlled substance logs and ordering patterns quarterly; ensure your dispensing system generates a compliant suspicious order report.

5. Fake Electronic Prescriptions (E-Script Fraud)
▲ Trending up

DEA has issued warnings about large-scale electronic prescription fraud — tens of thousands of fake controlled-substance prescriptions filled using stolen or fabricated clinician credentials by exploiting vulnerabilities in e-prescribing software. Pharmacies that filled these prescriptions face civil and criminal exposure even if they were unaware of the fraud.

Recent examples:

What to watch: Verify prescriber DEA registration number and identity on every electronic prescription for a Schedule II controlled substance; flag repeated new-patient CII orders originating from a single prescriber NPI or DEA number that appear inconsistent with the prescriber's specialty or practice location.

6. Illegal Online Pharmacies (Operation Meltdown, Feb 2026)
▲ Trending up

In February 2026, DEA seized more than 200 internet domains tied to an India-based transnational criminal organization that filled hundreds of thousands of diverted and counterfeit pill orders. The operation resulted in 4 arrests and Immediate Suspension Orders against participating U.S. registrants, and was linked to at least 6 fatal and 4 non-fatal overdoses.

Recent examples:

What to watch: Patients may obtain diverted or counterfeit drugs through online channels and then present at emergency departments with unexpected overdose presentations. ED discharge staff and social workers benefit from awareness training on online diversion as a patient-safety issue, not just a supply-chain one.

7. AI/Analytics Surveillance Becoming the Expected Standard
▲ Trending up

Machine-learning and analytics-based detection is moving from innovative to expected. Peer-reviewed literature shows detection times dropping from a mean of 160 days to days or weeks when integrated EMR and ADC data are analyzed with ML models. Healthcare facilities without a formal analytics surveillance program are increasingly outliers — and accreditors and regulators are beginning to notice.

Recent examples:

What to watch: If you don't yet run analytics surveillance, expect regulators and accreditors to start asking why not. See Analytics Dashboard for a build blueprint you can use with existing EMR and ADC data exports.

CONTEXT
Why It Matters — Key Statistics
~1 in 10

healthcare workers misuses or diverts drugs at some point in their career

Source: Bluesight / Premier CE
81%

of healthcare leaders believe diversion continues to occur frequently at their organizations

Source: Wolters Kluwer 2025 State of Drug Diversion Survey
~2×

the mortality risk from substance misuse for anesthesia providers compared to other healthcare specialties

Source: AANA / Sigma Repository
Assess your diversion prevention program

Run the hospital checklist to see where your program stands against the trends above.

Assess your program
Read the case studies

Real-world diversion events with analysis, sentencing outcomes, and prevention lessons.

Read the case studies
Share: LinkedIn X Facebook

Last reviewed: September 2026 · Content is educational, not legal advice.

Related Resources
Diversion Settlements & Fines

Settlements, civil penalties and criminal fines paid by hospitals and pharmacies in documented drug diversion cases, with the amount, year and primary source for each
Drug Diversion Statistics

Charts and data tables from 716 documented federal and state cases — drugs, settings, outcomes, and cases by year
Prevention Value Deck (Download)

Free 10-slide PowerPoint that makes the case for a diversion prevention program — documented penalties, deaths and how to evidence your own value, every figure cited
Investigation Playbook

Step-by-step guide from initial report through resolution and corrective action